Alnylam Pharmaceuticals
ALNY
#643
Rank
S$42.41 B
Marketcap
$327.66
Share price
-1.30%
Change (1 day)
62.51%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company